A detailed history of Tower Research Capital LLC (Trc) transactions in Immucell Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,116 shares of ICCC stock, worth $5,267. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,116
Previous 1,767 36.84%
Holding current value
$5,267
Previous $8,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.53 - $4.46 $2,298 - $2,903
-651 Reduced 36.84%
1,116 $4,000
Q2 2024

Aug 13, 2024

SELL
$4.18 - $5.48 $986 - $1,293
-236 Reduced 11.78%
1,767 $8,000
Q1 2024

May 15, 2024

SELL
$4.73 - $5.47 $288 - $333
-61 Reduced 2.96%
2,003 $10,000
Q4 2023

Feb 13, 2024

BUY
$4.45 - $5.47 $1,909 - $2,346
429 Added 26.24%
2,064 $10,000
Q3 2023

Nov 14, 2023

SELL
$4.53 - $5.61 $12,534 - $15,522
-2,767 Reduced 62.86%
1,635 $8,000
Q2 2023

Aug 14, 2023

BUY
$4.64 - $5.98 $9,590 - $12,360
2,067 Added 88.52%
4,402 $22,000
Q1 2023

May 09, 2023

BUY
$4.85 - $7.84 $5,136 - $8,302
1,059 Added 82.99%
2,335 $12,000
Q4 2022

Feb 10, 2023

BUY
$6.09 - $8.25 $7,770 - $10,527
1,276 New
1,276 $8,000
Q2 2022

Aug 15, 2022

BUY
$7.7 - $10.71 $1,178 - $1,638
153 New
153 $1,000
Q1 2022

May 12, 2022

SELL
$8.0 - $10.06 $800 - $1,006
-100 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$8.0 - $9.74 $800 - $974
100 New
100 $1,000
Q3 2021

Nov 15, 2021

SELL
$8.54 - $10.24 $3,638 - $4,362
-426 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$8.5 - $10.95 $2,720 - $3,504
-320 Reduced 42.9%
426 $4,000
Q1 2021

May 17, 2021

BUY
$5.98 - $11.88 $3,372 - $6,700
564 Added 309.89%
746 $7,000
Q4 2020

Feb 16, 2021

SELL
$5.21 - $6.42 $651 - $802
-125 Reduced 40.72%
182 $1,000
Q3 2020

Nov 16, 2020

BUY
$4.98 - $6.35 $1,528 - $1,949
307 New
307 $2,000
Q1 2020

May 15, 2020

SELL
$3.79 - $5.92 $6,719 - $10,496
-1,773 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$4.81 - $5.57 $4,502 - $5,213
936 Added 111.83%
1,773 $9,000
Q3 2019

Nov 05, 2019

BUY
$5.15 - $6.55 $4,001 - $5,089
777 Added 1295.0%
837 $5,000
Q2 2019

Aug 13, 2019

SELL
$5.89 - $6.86 $3,857 - $4,493
-655 Reduced 91.61%
60 $0
Q1 2019

May 14, 2019

BUY
$5.91 - $8.09 $1,022 - $1,399
173 Added 31.92%
715 $5,000
Q4 2018

Feb 14, 2019

BUY
$6.4 - $9.03 $1,580 - $2,230
247 Added 83.73%
542 $4,000
Q3 2018

Nov 13, 2018

BUY
$6.5 - $8.99 $825 - $1,141
127 Added 75.6%
295 $2,000
Q2 2018

Aug 15, 2018

BUY
$6.75 - $8.28 $1,134 - $1,391
168 New
168 $1,000
Q1 2018

May 15, 2018

SELL
$6.93 - $8.27 $367 - $438
-53 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$6.74 - $9.23 $357 - $489
53
53 $0

Others Institutions Holding ICCC

About IMMUCELL CORP


  • Ticker ICCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,746,860
  • Market Cap $36.6M
  • Description
  • ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...
More about ICCC
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.